These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19235767)

  • 1. Human natural killer receptors, co-receptors, and their ligands.
    Biassoni R
    Curr Protoc Immunol; 2009 Feb; Chapter 14():14.10.1-14.10.40. PubMed ID: 19235767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Natural Killer Receptors, Co-Receptors, and Their Ligands.
    Biassoni R; Malnati MS
    Curr Protoc Immunol; 2018 Apr; 121(1):e47. PubMed ID: 30040219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
    Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
    Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses.
    Nedvetzki S; Sowinski S; Eagle RA; Harris J; Vély F; Pende D; Trowsdale J; Vivier E; Gordon S; Davis DM
    Blood; 2007 May; 109(9):3776-85. PubMed ID: 17218381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell licensing during viral infection.
    Orr MT; Lanier LL
    Adv Exp Med Biol; 2011; 780():37-44. PubMed ID: 21842363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
    Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
    J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human NK cells: From surface receptors to clinical applications.
    Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
    Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.
    Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
    Immunol Lett; 2005 Aug; 100(1):7-13. PubMed ID: 16109445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of self-ligands for activating natural killer cell receptors.
    Lam RA; Chwee JY; Le Bert N; Sauer M; Pogge von Strandmann E; Gasser S
    Ann Med; 2013 Jun; 45(4):384-94. PubMed ID: 23701136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory NK cells in autoimmune disease.
    Tian Z; Gershwin ME; Zhang C
    J Autoimmun; 2012 Sep; 39(3):206-15. PubMed ID: 22704425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC-I molecules selectively inhibit cell-mediated cytotoxicity triggered by ITAM-coupled activating receptors and 2B4.
    Corral-San Miguel R; Hernández-Caselles T; Ruiz Alcaraz AJ; Martínez-Esparza M; García-Peñarrubia P
    PLoS One; 2014; 9(9):e107054. PubMed ID: 25226085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bird's eye view of NK cell receptor interactions with their MHC class I ligands.
    Saunders PM; Vivian JP; O'Connor GM; Sullivan LC; Pymm P; Rossjohn J; Brooks AG
    Immunol Rev; 2015 Sep; 267(1):148-66. PubMed ID: 26284476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function.
    Tremblay-McLean A; Coenraads S; Kiani Z; Dupuy FP; Bernard NF
    BMC Immunol; 2019 Jan; 20(1):8. PubMed ID: 30696399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cells.
    Rosental B; Appel MY; Yossef R; Hadad U; Brusilovsky M; Porgador A
    Curr Med Chem; 2012; 19(12):1780-91. PubMed ID: 22414084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets.
    Wahle JA; Paraiso KH; Costello AL; Goll EL; Sentman CL; Kerr WG
    J Immunol; 2006 Jun; 176(12):7165-9. PubMed ID: 16751359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction during activation and inhibition of natural killer cells.
    Watzl C; Long EO
    Curr Protoc Immunol; 2010 Aug; Chapter 11():Unit 11.9B. PubMed ID: 20814939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.
    Lu L; Ikizawa K; Hu D; Werneck MB; Wucherpfennig KW; Cantor H
    Immunity; 2007 May; 26(5):593-604. PubMed ID: 17509909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More.
    Vitale M; Cantoni C; Della Chiesa M; Ferlazzo G; Carlomagno S; Pende D; Falco M; Pessino A; Muccio L; De Maria A; Marcenaro E; Moretta L; Sivori S
    Front Immunol; 2019; 10():1415. PubMed ID: 31316503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory Receptor Crosslinking Quantitatively Dampens Calcium Flux Induced by Activating Receptor Triggering in NK Cells.
    Ganesan S; Höglund P
    Front Immunol; 2018; 9():3173. PubMed ID: 30693005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.